Paul Lountzis
Lountzis Asset Management
Paul Lountzis Elevance Health Inc stake
total: 139
Lountzis Asset Management ELV trades
- Total transactions:
- 4
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 1
- Held since:
- 2023 Q1
- Held for:
- 10 quarters
- Latest activity:
- 2025 Q3
According to 2026 Q2 report, Paul Lountzis doesn't hold any Elevance Health Inc (ELV) shares. To date, the estimated cost basis is nearly $471.07 for "buy" trades and estimated average "sell" price is $393.68. Lountzis Asset Management first purchased ELV in 2023 Q1, initially acquiring 755 shares. Since the initial investment in Elevance Health Inc (ELV), Lountzis Asset Management has made 3 more transactions.
When did Paul Lountzis sell Elevance Health Inc (ELV)?
Paul Lountzis sold off the entire Elevance Health Inc (ELV) position in 2025 Q3.
When did Paul Lountzis buy Elevance Health Inc (ELV)?
Paul Lountzis first invested in Elevance Health Inc (ELV) in 2023 Q1 at the reported quarter-end price of $459.60 per share.
What's the cost basis of Lountzis Asset Management's ELV stake?
The estimated cost basis for Elevance Health Inc (ELV) stake is around $471.07 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $471.07
- Weighted AVG sell price:
- $393.68
Paul Lountzis's historical trades in Elevance Health Inc
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q3
|
0.00%
|
0
|
$388.96
|
|
-100% (-755)
|
-0.1%
|
|
2025 Q1
|
0.12%
|
755
|
$413.82
|
$312,434
|
-18.99% (-177)
|
-0.03%
|
|
2024 Q3
|
0.20%
|
932
|
$520.00
|
$484,640
|
+23.44% (+177)
|
+0.04%
|
|
2023 Q1
|
0.21%
|
755
|
$459.60
|
$347,000
|
new
|
+0.21%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.